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Background: To achieve effective regeneration of injured myocardium, it is important to find a more effective way of improving the cardiogenic 
differentiation of MSCs in in vitro. In previous study, we showed that treatment of MSCs with a protein kinase C inhibitor suppressed the expression 
of cardiogenic markers. In this study, we hypothesize that the activation of protein kinase C induces the differentiation of MSCs into cardiogenic cells 
(CGCs) and the implantation of CGCs regenerates the infarcted myocardium more efficiently than intact MSCs.
Methods & Results: We have determined the effect of phorbol myristate acetate (PMA), a PKC activator, on cardiogenic differentiation of 
mesenchymal stem cells (MSCs) using sandwich ELISA assay. PMA treated MSCs showed the increased level of cardiac specific markers, such as 
cTnT, MLC, MHC, NKX 2.5, and MEF 2 with time dependent manner up to 9 days. In addition, α- and β- adrenergic, and muscarinic receptors, 
significantly increased and they were functionally reacted against norephinephrine stimulus. The mRNA levels of sarcoplasmic reticulum Ca2+-ATPase 
(SERCA 2a) and L-type Ca2+ channel (LTCC) in PMA treated MSCs were increased to similar levels in cardiomyocytes. Intramyocardial transplantation 
of CGCs into ischemic injured hearts significantly decreased interstitial fibrosis to 2.5±1.0% compared to MSCs control of 18±3.2%. TUNEL-positive 
cells caused by ischemic injury were significantly reduced by 45.0% in CGCs-transplanted group compared with MSCs group. Interestingly, though 
the mRNA levels of growth factors, such as HGF and VEGF were increased, inflammation cytokines like TNF-α, IL-1β, and IL-6 were significantly 
decreased in CGCs-transplanted groups compared to MSCs transplanted control.
Conclusions: These results suggest that regulation of protein kinase C activation could be a leading method for differentiation of stem cells into 
cardiomyocytes, and they may help to clarify the cascade of transcriptional activation that regulates differentiation into cardiogenic cells (CGCs) of 
MSCs. These results also contribute to a better therapeutic understanding of pre-differentiated MSCs on cardiac disease.
